---
$id: https://graph.org.ai/products/commodity/51131811
$type: Product
source: UNSPSC
code: "51131811"
title: "Tranexamic acid"
class: "51131800"
classTitle: "Coagulants and systemic hemostatic agents"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tranexamic acid

**UNSPSC Code**: 51131811
**Class**: [Coagulants and systemic hemostatic agents](Coagulants and systemic hemostatic agents.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a hemostatic agent with the molecular formula C8H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6T84R30KC1, chemically known as rp 18,429 but generally known as tranexamic acid, which bears US NIH Compound Identifier 5526. European Medicines Agency schedules Tranexamic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11214MIG. The term TRANEXAMIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules tranexamic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule tranexamic acid under HS 29224995 and SITC 51465. As of Q4 2014, TRANEXAMIC ACID remains the US FDA Preferred Term for this commodity. Tranexamic acid bears US NLM identifiers UMLS ID C0040613 and NCI Concept Code C47765. SMILES: OC(=O)C1CCC(CC1)CN.

